Category: Zimmer HoldingsSyndicate content

Exclusive: IRS collected $1.4B in medtech excise tax payments in 2013

July 28, 2014 by Brian Johnson

The IRS calculates that medtech companies paid the federal government $1.4 billion in medical device excise taxes in 2013, according to a response to a Freedom of Information Act request by MassDevice.com.

MassDevice.com coverage of the medical device tax

Medical device companies ponied up $1.4 billion in excise tax payments to the federal government in 2013 to pay for Obamacare, according to documents supplied to MassDevice.com by the Internal Revenue Service.

Zimmer slides on Q2 sales miss, lowered outlook

July 24, 2014 by Brad Perriello

Zimmer Holdings misses 2nd-quarter sales expectations, just meets Wall Street's earnings forecast and cuts its 2014 guidance, sending share prices down this morning.

Zimmer slides on Q2 sales miss

Zimmer (NYSE:ZMH) shares are down this morning after the orthopedic device maker reported disappointing 2nd-quarter results and cut its outlook for the rest of the year.

Covidien names Bill Burke as CFO to lead Medtronic merger | The week in medtech M&A

July 9, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Covidien taps integration chief to navigate Medtronic merger; Zimmer, Biomet appoint integration team; Thoratec inks $75M deal for Apica Cardiovascular; FTC wants more from Zimmer, Biomet on merger; Johnson & Johnson closes Ortho-Clinical Diagnostics sale

Covidien taps integration chief to navigate Medtronic merger

July 3, 2014 by Arezu Sarvestani

Covidien taps integration chief to navigate Medtronic merger

FTC wants more from Zimmer, Biomet on merger

July 2, 2014 by Brad Perriello

The U.S. Federal Trade Commission wants more information from Zimmer Holdings and Biomet on their proposed, $13 billion merger.

FTC wants more from Zimmer, Biomet on merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Zimmer, Biomet appoint integration team

July 1, 2014 by Brad Perriello

Zimmer Holdings and Biomet tap executives from both companies for a team to guide their integration after their pending $13 billion merger closes.

Zimmer, Biomet appoint integration team

Zimmer (NYSE:ZMH) and Biomet appointed executives from both companies to manage their integration after their pending, $13 billion merger goes through.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic acquires Covidien in a $43 billion deal | Medtech Wall Street news for the week of June 16, 2014

June 19, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Blockbuster: Medtronic in $43B deal to acquire Covidien; Medtronic buyout holds $80M in golden parachutes for Covidien execs; FDA wants another panel hearing on Boston Scientific's Watchman anti-stroke device; European Commission tables review of Zimmer's $13B acquisition of Biomet; Ackman takes Allergan to court to defend against poison pill

Blockbuster: Medtronic in $43B deal to acquire Covidien

June 16, 2014 by Brad Perriello

Blockbuster: Medtronic in $43B deal to acquire Covidien

European Commission tables review of Zimmer's $13B acquisition of Biomet

June 13, 2014 by Brad Perriello

The European Commission tables its review of Zimmer Holdings' $13 billion acquisition bid for cross-town orthopedics rival Biomet, saying Zimmer's submission is incomplete.

European Commission tables review of Zimmer's $13B acquisition of Biomet

The European Commission tabled its review of the pending, $13.35 billion merger between Zimmer (NYSE:ZMH) and Biomet, saying Zimmer's submission for the June 3 review was insufficient.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp